nialamide has been researched along with Metabolic Diseases in 1 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KNICK, B | 1 |
1 other study available for nialamide and Metabolic Diseases
| Article | Year |
|---|---|
[Clinical and experimental data on the neurohumoral vascular and tissue effects of nialamide in cardiovascular and metabolic diseases].
Topics: Adrenal Cortex Hormones; Cardiovascular Diseases; Cardiovascular System; Heart Diseases; Humans; Met | 1962 |